163 Aspirin Utilization in Patients with Nonvalvular Atrial Fibrillation on Oral Anticoagulants in a Large Academic Medical Center

163 Aspirin Utilization in Patients with Nonvalvular Atrial Fibrillation on Oral Anticoagulants in a Large Academic Medical Center

Saved in:

Bibliographic Details
Main Authors:	Morgan Quinn, Andrew Galascio, Jennifer Mazur, Sienna Miller, Joli Fermo, Aulbrey Drisaldi, David Cruse, Emily Ware
Format:	Article
Language:	English
Published:	Elsevier 2025-05-01
Series:	Research and Practice in Thrombosis and Haemostasis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2475037925000925
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Anticoagulation control for nonvalvular atrial fibrillation in a tertiary academic centre in Johannesburg
by: Vanessa Mogashoa, et al.
Published: (2024-10-01)

NOVEL ANTICOAGULANTS FOR THROMBOEMBOLIC COMPLICATIONS PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION
by: D. A. Itkin, et al.
Published: (2015-02-01)

Efficiency of the Left Atrial Appendage Thrombus Dissolution in Patients with Persistent Nonvalvular Atrial Fibrillation with Warfarin or Direct Oral Anticoagulants Therapy
by: E. S. Mazur, et al.
Published: (2021-11-01)

PRACTICAL CONCERNS OF ANTICOAGULATION IN NONVALVULAR ATRIAL FIBRILLATION: A UNIVERSITY CLINICS REGISTRY
by: A. A. Sokolova, et al.
Published: (2015-09-01)

Features of Modern Anticoagulant Therapy in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease
by: I. S. Daabul, et al.
Published: (2016-11-01)

Predictors of Thrombus Dissolution in the Left Atrial Appendage in Patients with Persistent Nonvalvular Atrial Fibrillation
by: E. S. Mazur, et al.
Published: (2022-03-01)

Optimal choice of prophylactic anticoagulant therapy for nonvalvular atrial fibrillation in the context of COVID-19 pandemic
by: A. S. Polyakov, et al.
Published: (2021-09-01)

Incidence of nonvalvular atrial fibrillation and oral anticoagulant prescribing in England, 2009 to 2019: A cohort study.
by: Alyaa M Ajabnoor, et al.
Published: (2022-06-01)

Efficacy and Safety of Direct Oral Anticoagulants in Patients with Diabetes and Nonvalvular Atrial Fibrillation: Meta-Analysis of Observational Studies
by: Bo Cao, et al.
Published: (2021-01-01)

Effect of drug interactions with non-vitamin-K oral anticoagulants on thromboembolic events in patients with nonvalvular atrial fibrillation
by: Jin-Hua Chen, et al.
Published: (2024-02-01)

ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION: PROBLEMS AND PROSPECTS
by: A. Y. Rychkov, et al.
Published: (2016-01-01)

Main factors of adherence to new oral anticoagulants and its dynamics in outpatients with nonvalvular atrial fibrillation: results of the ANTEY study
by: Yu. V. Lukina, et al.
Published: (2020-11-01)

THE SELECTION PROBLEMS OF ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION WITH COMORBIDITIES
by: N. A. Koziolova, et al.
Published: (2015-08-01)

Concomitant Drug Interactions With Non–Vitamin K Oral Anticoagulants Are Associated With Bleeding and Mortality Risk in Patients With Nonvalvular Atrial Fibrillation
by: Chun‐Ka Wong, et al.
Published: (2025-05-01)

Dabigatran and warfarin in nonvalvular atrial fibrillation or atrial flutter in outpatient clinic practice in Brazil
by: Jean Michell Correia Monteiro, et al.

Fibrosis biomarkers as predictors of left atrial appendage thrombosis in patients with nonvalvular atrial fibrillation
by: T. P. Gizatulina, et al.
Published: (2022-08-01)

Predictors of spontaneous echo contrast and left atrial appendage thrombosis in nonvalvular atrial fibrillation
by: N. Yu. Khorkova, et al.
Published: (2020-08-01)

195 Evaluation of Various Treatment Strategies for Acquired Hemophilia A
by: Agnes Musyoka, et al.
Published: (2025-05-01)

Evaluating Major Bleeding Risks with Concomitant Use of Direct Oral Anticoagulants and Selective Serotonin Reuptake Inhibitors in Nonvalvular Atrial Fibrillation Patients
by: Shu-Yu Yao, et al.
Published: (2025-03-01)

EFFICACY AND SAFETY OF DIRECT ORAL ANTICOAGULANTS IN THE PREVENTION OF STROKE IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION IN EVERYDAY CLINICAL PRACTICE: FACTS ABOUT RIVAROXABAN
by: I. S. Yavelov
Published: (2016-07-01)

ENDOVASCULAR METHODS FOR CLOSURE OF THE LEFT ATRIAL APPENDAGE IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION FOR STROKE PREVENTION
by: R. V. Guchaev, et al.
Published: (2018-05-01)

Predictive Value of Blood and Echocardiographic Indicators for Nonvalvular Atrial Fibrillation in Postmenopausal Women
by: Lei Song, et al.
Published: (2025-03-01)

Direct Oral Anticoagulants in Patients Undergoing Urgent Reperfusion for Nonvalvular Atrial Fibrillation-Related Ischemic Stroke: A Brief Report on Literature Evidence
by: Luca Masotti, et al.
Published: (2019-01-01)

Construction of a Clinical Predictive Model of Left Atrial and Left Atrial Appendage Thrombi in Patients with Nonvalvular Atrial Fibrillation
by: Lei Yin, et al.
Published: (2022-01-01)

AGE AND EFFECTIVENESS AND SAFETY OF VARIOUS ANTITHROMBOTIC THERAPY VARIANTS IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION
by: V. I. Shevelev, et al.
Published: (2013-02-01)

Dabigatran etexilate in patients with nonvalvular atrial fibrillation: benefits of application in certain clinical situations
by: E. I. Baranova, et al.
Published: (2019-11-01)

Aspirin Compared to Low Intensity Anticoagulation in Patients with Non-Valvular Atrial Fibrillation. A Systematic Review and Meta-Analysis.
by: Fernando J Vazquez, et al.
Published: (2015-01-01)

Thromboembolic risk factors and predictors of left atrial appendage thrombosis in Far North patients with nonvalvular atrial fibrillation
by: N. Yu. Khorkova, et al.
Published: (2021-11-01)

Relationship between Brain Natriuretic Peptide and Thromboembolic Events in Elderly Patients with Nonvalvular Atrial Fibrillation
by: Hongxia Wang, et al.
Published: (2024-01-01)

Dabigatran etexilate for nonvalvular atrial fibrillation in real practice and promises for its use to prevent stroke
by: A.V. Fonyakin
Published: (2014-06-01)

Predicting of Long-term Maintenance of Sinus Rhythm after Cardioversion in Patients with Nonvalvular Persistent Atrial Fibrillation
by: Zharinov O., et al.
Published: (2014-12-01)

Anticoagulation in Atrial Fibrillation With Valvular Heart Disease
by: Ana Catarina Fonseca, et al.
Published: (2025-02-01)

Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation
by: Yu. P. Skirdenko, et al.
Published: (2020-05-01)

The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
by: I. Yu. Koroleva, et al.
Published: (2016-11-01)

Atrial Fibrillation Ablation without Interruption of Anticoagulation
by: Pasquale Santangeli, et al.
Published: (2011-01-01)

Factors related to the choice of warfarin for treating newly diagnosed nonvalvular atrial fibrillation are associated with safety outcomes during anticoagulation: A new‐user, active‐comparator, retrospective cohort study
by: Yoshiko Takagi, et al.
Published: (2024-12-01)

COMPARISON OF THE EFFECTS OF FOUR ANTIHYPERTENSIVE THERAPY VARIANTS ON ARTERIAL WALL ELASTICITY IN ELDERLY PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION
by: V. I. Shevelev, et al.
Published: (2013-08-01)

Long-Term Costs of Ischemic Stroke and Major Bleeding Events among Medicare Patients with Nonvalvular Atrial Fibrillation
by: Catherine J. Mercaldi, et al.
Published: (2012-01-01)

THROMBUS OF LEFT ATRIUM AND/OR ITS APPENDAGE IN CASE OF NONVALVULAR ATRIAL FIBRILLATION: FREQUENCY OF DETECTION AND CLINICAL RISK FACTORS
by: I. A. Zaigrayev, et al.
Published: (2020-01-01)

DABIGATRAN ETEXILATE FOR PREVENTION OF CARDIOEMBOLIC COMPLICATIONS IN NONVALVULAR ATRIAL FIBRILLATION: HOW TO DO THE INTERVENTION MORE EFFECTIVE AND SAFER
by: I. S. Yavelov
Published: (2016-01-01)